Regeneron Pharmaceuticals Inc.

NMS: REGN
Pharmaceuticals
Tarrytown NY
Title 1Chairman
Executive 1Dr. P. Roy Vagelos, M.D., Chairman | Chairman
2015 Revenue (US$ Millions)$4,104
2014 Revenue (US$ Millions)$2,820
Revenue Growth (%)45.55%
Net Income (US$ Millions)$636
Common Shares Outstanding (Millions)$105
Earnings Per Share (US$)$5.52
Price To Earnings Ratio96.01
Total Equity (US$ Millions)$3,655
Return On Equity (%)25.02%
Long Term Debt (US$ Millions)$363
Debt To Equity Ratio (%)0.10%
Market Capitalization (US$ Millions)$56,811
Total Assets (US$ Millions)$5,609
Current Assets (US$ Millions)$2,915
Inventories (US$ Millions)$239
Current Liabilities (US$ Millions)$811
Cost of Goods Sold (US$ Millions)$393
Asset Turnover0.73
Inventory Turnover2.14